Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota

Mayo Clinic Proceedings

Volumn 76, Issue 6, 2001, Pages 593-599

  Pillemer, Stanley R ^a,g,h   Matteson, Eric L ^b   Jacobsson, Lennart T H ^c   Martens, Peter B ^d   Joseph Melton W Michael O'Fallon, L ^e   Fox, Philip C ^f  

^a National Institutes of Dental and Craniofacial Research   (United States)

^b Division of Rheumatology and Internal Medicine   (United States)

^c Section of Clinical Epidemiology   (United States)

^d Department of Neurology   (United States)

^e MAYO CLINIC   (United States)

^f LUND UNIVERSITY   (Sweden)

^g South Shore Internal Medicine Associates   (United States)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

ANA = antinuclear antibody; CI = confidence interval; HIV = human immunodeficiency virus; KCS = keratoconjunctivitis sicca; RA = rheumatoid arthritis; SLE = systemic lupus erythematosus; SS = Sj gren syndrome; XS = xerostomia

Indexed keywords

ADULT; AGED; ARTICLE; CAUCASIAN; FEMALE; HUMAN; INCIDENCE; KERATOCONJUNCTIVITIS SICCA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; SALIVARY GLAND DISEASE; SERODIAGNOSIS; SJOEGREN SYNDROME; UNITED STATES; XEROSTOMIA;

EID: 0034995231     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.6.593     Document Type: Article

References (42)

1. Shearn MA. Sjögren's syndrome. Med Clin North Am. 1977; 61:271-282.
2. Anderson LG, Talal N. The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol. 1972:10:199-221.
3. Bloch KJ, Buchanan WW. Wohl MJ. Bunim JJ. Sjögren's syndrome: a clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore). 1965;44:187-231.
4. Drosos AA, Andonopoulos AP, Costopoulos JS, Papadimitriou CS. Moutsopoulos HM. Prevalence of primary Sjögren's syndrome in an elderly population. Br J Rheumatol. 1988;27:123-127.
5. Whaley K, Williamson J, Wilson T, et al. Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing. 1972; 1:197-206.
6. Strickland RW, Tesar JT, Berne BH, Hobbs BR, Lewis DM, Welton RC. The frequency of sicca syndrome in an elderly female population. J Rheumatol. 1987; 14:766-771.
7. Sjögren H. Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis Filiformis bei Hypofunktion der Tränendrüsen). Acta Ophthalmol (Copenh). 1933;11(suppl 2): 1-151.
8. Jacobsson LT, Axell TE, Hansen BU, et al. Dry eyes or mouth-an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome. J Autoimmun. 1989;2:521-527.
9. Zhang NZ, Shi CS, Yao QP, et al. Prevalence of primary Sjögren's syndrome in China. J Rheumatol. 1995;22:659-661.
10. Tomsic M, Logar D, Grmek M, Perkovic T, Kveder T. Prevalence of Sjögren's syndrome in Slovenia. Rheumatologv (Oxford). 1999; 38:164-170.
11. Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren's syndrome: a community-based study of prevalence and impact. BrJ Rheumatol. 1998:37:1069-1076.
12. Manthorpe R, Oxholm P, Prause JU, Schiodt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol Suppl. 1986; 61:19-21.
13. Skopouli FN, Drosos AA, Papaioannou T, Moutsopoulos HM. Preliminary diagnostic criteria for Sjögren's syndrome. Scand J Rheumatol Suppl. 1986;61:22-25.
14. Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol Suppl. 1986:61:26-27.
15. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum. 1986:29:577-585.
16. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36:340-347.
17. Fox RI, Saito I. Criteria for diagnosis of Sjögren's syndrome. Rheum Dis Clin North Am. 1994;20:391-407.
18. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-274.
19. Bergstralh EJ, Offord KP, Chu C-P, Beard CM, O'Fallon WM, Melton LJ III. Calculating incidence, prevalence and mortality rates for Olmsted County, Minnesota residents: an update. Technical Report Series, No. 49. Rochester, Minn: Section of Biostatistics. Mayo Clinic; March 1992.
20. Kurland LT, Hauser WA, Ferguson RH, Holley KE. Epidemiologie features of diffuse connective tissue disorders in Rochester, Minn, 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc. 1969;44:649-663.
21. Michel CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1985;60:105-113.
22. Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore. Maryland, 1970-1911. Arthritis Rheum. 1985:28:80-86.
23. Jonsson H, Nived O. Sturfeit G, Silman A. Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol. 1990:29:185-188.
24. Gudmundsson S, Steinsson K. Systemic lupus erythematosus in Iceland 1975 through 1984: a nationwide epidemiological study in an unselected population. J Rheumatol. 1990:17:1162-1167.
25. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, Laporte RE, Kwoh CK. Incidence of systemic lupus erythematosus: race and gender differences. Arthritis Rheum. 1995:38:12601270.
26. Johnson AE, Gordon C. Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England: relationship to ethnicity and country of birth. Arthritis Rheum. 1995:38:551-558.
27. Linos A. Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol. 1980:111: 87-98.
28. Atkinson JC, Wu AJ. Salivary gland dysfunction: causes, symptoms, treatment. J Am Dent Assoc. 1994; 125:409-416.
29. Billings RJ. Proskin HM, Moss ME. Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol. 1996;24:312-316.
30. Nederfors T. Xerostomia: prevalence and pharmacotherapy: with special reference to beta-adrenoceptor antagonists. Swed Dent J Suppl. 1996:116:1-70.
31. Thomson WM, Brown RH, Williams SM. Medication and perception of dry mouth in a population of institutionalised elderly people. NZMedJ. 1993:106:219-221.
32. Locker D. Subjective reports of oral dryness in an older adult population. Community- Dent Oral Epidemiol. 1993;21:165-168.
33. Osterberg T, Birkhed D, Johansson C, Svanborg A. Longitudinal study of stimulated whole saliva in an elderly population. Scand J Dent Res. 1992:100:340-345.
34. O'Grady NP. Incidence of dry mouth complaint in Cork Dental Hospital patient population. Stoma (Li.sb). August-October 1990:2: 55-56. 58.
35. Chisholm DM, Waterhouse JP, Mason DK. Lymphocytic sialadenitis in the major and minor glands: a correlation in postmortem subjects. J Clin Palhol. 1970:23:690-694.
36. Damato BE, Allan D, Murray SB, Lee WR. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol. 1984:68:674-680.
37. Tomer Y, Shoenfeld Y. Ageing and autoantibodies. Autoimmunity. 1988:1:141-149.
38. Jacobsson L, Hansen BU. Manthorpe R, Hardgrave K, Neas B, Harley JB. Association of dry eyes and dry mouth with anti-Ro/SSA and anti-La/SS-B autoantibodies in normal adults. Arthritis Rheum. 1992:35:1492-1501.
39. Vitali C, Bombardieri S, Moutsopoulos HM, et al, European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis. 1996:55:116-121.
40. Sibilia J. Ro(SS-A) and anti-Ro(SS-A): an update. Rev Rhum Engl Ed. 1998:65:45-57.
41. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB. Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health. 1999:89:14-18.
42. Feng X. Hepatitis C infection: a review. Lippincotts Prim Care Pract. 1999:3:345-353.